Skip to content

Supplier News

P&G names Taylor as next CEO

P&G names Taylor as next CEO

David Taylor, Procter & Gamble Co.’s group president of global beauty, grooming and health care, has been chosen to succeed A.G. Lafley as the company’s president and chief executive officer. P&G said late Tuesday that Taylor is slated to take the helm as CEO on Nov.

Sandoz releases Pulmicort Respules generic

Sandoz has launched budesonide inhalation suspension, an asthma medication, in the U.S. market. The Novartis subsidiary said Tuesday that it will market its budesonide inhalation suspension in 1-mg strength, and it expects 180-day generic drug marketing exclusivity for that dosage.

Qore-24 hits shelves at Walgreens stores

Qore-24 hits shelves at Walgreens stores

Qore-24, an antimicrobial hand purifier that kills germs for up to 24 hours, has landed retail distribution at Walgreens. Qore Systems, the maker of Qore-24, said Tuesday that the product began rolling out to 3,700 Walgreens stores nationwide earlier this month.

Yes To tabs Jackel as CEO

Yes To tabs Jackel as CEO

Ingrid Jackel is joining natural beauty care manufacturer Yes To Inc. as chief executive officer. Yes To said Monday that Jackel comes to Yes To from Physicians Formula, where she held a variety of positions, including CEO, president and chairwoman.

Galderma set to launch Epiduo Forte Gel

Galderma set to launch Epiduo Forte Gel

Galderma Laboratories has received Food and Drug Administration approval for antibiotic-free Epiduo Forte Gel (adapalene and benzoyl peroxide 0.3%/2.5%), a once-daily topical acne treatment. Galderma said Thursday Epiduo Forte Gel is the first combination of 0.3%/2.